Articles | Open Access | Vol. 3 No. 05 (2023): Volume 03 Issue 05 | DOI: https://doi.org/10.37547/medical-fmspj-03-05-03

EXPLORING THE LINK BETWEEN INTERLEUKIN-10, CHOLESTEROL, AND BLOOD GLUCOSE LEVELS IN GEOHELMINTH-POSITIVE ADOLESCENTS AND ADULTS: A COMPARATIVE STUDY

Nuzulia Darwin , Department of Histology, Medical Faculty, Andalas University, Padang, Indonesia
Eryati Jonson , Department of Nutritional Science, Medical Faculty, Andalas University, Padang, Indonesia

Abstract

The abstract provides a concise summary of the study's objective, methods, results, and conclusions. This comparative study aims to explore the relationship between interleukin-10 (IL-10), cholesterol, and blood glucose levels in geohelminth-positive adolescents and adults. Geohelminth infections are prevalent in this population, and understanding their impact on these variables could provide valuable insights into the mechanisms underlying immune response, lipid metabolism, and glucose regulation. A sample of geohelminth-positive individuals was selected, and IL-10, cholesterol, and blood glucose levels were measured. Statistical analyses were conducted to examine associations and correlations among these variables. The results will contribute to our understanding of the complex interplay between IL-10, cholesterol, and blood glucose levels in the context of geohelminth infections, potentially uncovering novel avenues for intervention and management of related health conditions.

Keywords

Interleukin-10, Cholesterol, Blood glucose levels

References

BROOKER S, HOTEZ PJ, BUNDY DAP. HOOKWORM-RELATED ANAEMIA AMONG PREGNANT WOMEN: A SYSTEMATIC REVIEW. PLOS NEGL TROP DIS. 2008;2(9):E291.

HOTEZ PJ, BRINDLEY PJ, BETHONY JM, KING CH, PEARCE EJ, JACOBSON J. HELMINTH INFECTIONS: THE GREAT NEGLECTED TROPICAL DISEASES. J CLIN INVEST. 2008;118(4):1311-1321.

MAIZELS RM, HEWITSON JP, SMITH KA. SUSCEPTIBILITY AND IMMUNITY TO HELMINTH PARASITES. CURR OPIN IMMUNOL. 2012;24(4):459-466.

OSAKUNOR DNM, WOOLHOUSE MEJ, MUTAPI F. PAEDIATRIC INFECTION AND DISEASE AND THE LIFELONG CONSEQUENCES OF CHRONIC INFECTION. TRENDS PARASITOL. 2018;34(6):452-464.

O'GARRA A, BARRAT FJ, CASTRO AG, VICARI A, HAWRYLOWICZ C. STRATEGIES FOR USE OF IL-10 OR ITS ANTAGONISTS IN HUMAN DISEASE. IMMUNOL REV. 2008;223(1):114-131.

DE WAAL MALEFYT R, HAANEN J, SPITS H, RONCAROLO MG, TE VELDE A, FIGDOR C, ET AL. INTERLEUKIN 10 (IL-10) AND VIRAL IL-10 STRONGLY REDUCE ANTIGEN-SPECIFIC HUMAN T CELL PROLIFERATION BY DIMINISHING THE ANTIGEN-PRESENTING CAPACITY OF MONOCYTES VIA DOWNREGULATION OF CLASS II MAJOR HISTOCOMPATIBILITY COMPLEX EXPRESSION. J EXP MED. 1991;174(4):915-924.

REIS J, PORTUGAL-CARVALHO D, COSTA-RODRIGUES J, TEIXEIRA-COELHO M, PINTO R, SOUSA N, ET AL. INTERLEUKIN-10 IMPAIRS HUMAN MONOCYTE RESPONSE TO LPS: DECREASED IL-1RA AND TNF-Α AND INCREASED IL-1Β RELEASE. MEDIATORS INFLAMM. 2013;2013:823805.

MOEHLECKE M, CANANI LH, SILVA LO, TRINDADE MR, FRIEDMAN R, LEITÃO CB, ET AL. RELATIONSHIP BETWEEN INFLAMMATORY CYTOKINES AND LIPID ACCUMULATION IN DIFFERENTIATED 3T3-L1 ADIPOCYTES. J CELL BIOCHEM. 2010;111(3):673-678.

TABAS I, WILLIAMS KJ, BOREN J. SUBENDOTHELIAL LIPOPROTEIN RETENTION AS THE INITIATING PROCESS IN ATHEROSCLEROSIS: UPDATE AND THERAPEUTIC IMPLICATIONS. CIRCULATION. 2007;116(16):1832-1844.

FERENCE BA, GINSBERG HN, GRAHAM I, RAY KK, PACKARD CJ, BRUCKERT E, ET AL. LOW-DENSITY LIPOPROTEINS CAUSE ATHEROSCLEROTIC CARDIOVASCULAR DISEASE. 1. EVIDENCE FROM GENETIC, EPIDEMIOLOGIC, AND CLINICAL STUDIES. A CONSENSUS STATEMENT FROM THE EUROPEAN ATHEROSCLEROSIS SOCIETY CONSENSUS PANEL. EUR HEART J. 2017;38(32):2459-2472.

MOORADIAN AD. DYSLIPIDEMIA IN TYPE 2 DIABETES MELLITUS. NAT CLIN PRACT ENDOCRINOL METAB.

Article Statistics

Downloads

Download data is not yet available.

Copyright License

Download Citations

How to Cite

Nuzulia Darwin, & Eryati Jonson. (2023). EXPLORING THE LINK BETWEEN INTERLEUKIN-10, CHOLESTEROL, AND BLOOD GLUCOSE LEVELS IN GEOHELMINTH-POSITIVE ADOLESCENTS AND ADULTS: A COMPARATIVE STUDY. Frontline Medical Sciences and Pharmaceutical Journal, 3(05), 18–24. https://doi.org/10.37547/medical-fmspj-03-05-03